Assessment of orally dosed commercial silver nanoparticles on humanex vivoplatelet aggregation
- 20 March 2013
- journal article
- clinical trial
- Published by Taylor & Francis in Nanotoxicology
- Vol. 8 (3) , 328-333
Abstract
Enhanced in vitro human and ex vivo rat platelet aggregation from direct exposure to silver nanoparticles is previously reported. Given the increasing human use of engineered silver nanoscale products, platelet aggregation prompted by silver nanoparticles may contribute to human cardiovascular events. To understand how direct washed platelet exposure to silver nanoparticles translates to ex vivo platelet aggregation, the authors conducted a placebo-controlled, single-blind, dose-monitored, cross-over study design in 18 healthy human volunteers. After 2 weeks of daily oral silver nanoparticle ingestion, platelet aggregation was evaluated by light transmission aggregometry in response to collagen and ADP agonists, both at baseline and after silver nanoparticle or placebo diluent oral dosing. Final percent aggregation (PA) and the changes in PA were determined using a paired design (i.e., active and placebo solutions). Enhanced ex vivo platelet activation was not detectable at peak serum silver concentrations <10 µg/L. Further studies of colloidal silver nanoparticles on human platelet activities are warranted.Keywords
This publication has 24 references indexed in Scilit:
- Biocidal Efficacy of Silver-Impregnated Contact Lens Storage Cases In VitroInvestigative Ophthalmology & Visual Science, 2011
- Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activityNanotoxicology, 2010
- Use of Central Venous Catheter and Peripheral Venous Catheter as Risk Factors for Nosocomial Bloodstream Infection in Very-Low-Birth-Weight InfantsInfection Control & Hospital Epidemiology, 2010
- Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2009
- Pharmaceutical nanotechnology: More than sizeInternational Journal of Pharmaceutics, 2007
- Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approachJournal of Controlled Release, 2006
- An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cementBiomaterials, 2004
- Silver coated materials for external fixation devices: in vitro biocompatibility and genotoxicityBiomaterials, 2002
- Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphaticsAdvanced Drug Delivery Reviews, 2001
- Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controlsJournal of Internal Medicine, 1997